Table 2.

Galectin-3 (G3), laboratory and vascular measurements of participants with peripheral artery disease (PAD) and participants with normal ABI (ABI ≥1).

	ABI ≥1 (n=29)	PAD (n=31)	p Value
G3 (ng/mL)	14.4 (4.1)	17.6 (4.7)	0.0073
Laboratory
Hs-CRP# (mg/dL)	0.9 (0.4-2.8 )	2.25 (1-13.1)	0.0068*
UACR#	4.2 (2.8-5.9)	9.4 (4.4-29.5)	0.0031*
HOMA#	1.3 (0.7-2.4)	3.6 (1.4-8.2)	0.0008*
Vascular measures
LAEI (ml × mmHg-1) × 10	14.1 (3.7)	13.9 (6.2)	0.93
SAEI (ml × mmHg-1) × 100	5.3 (2.9)	3.1 (1.3)	<0.001
SBP (mmHg)	126 (14)	133 (24)	0.13
DBP (mmHg)	72 (9)	71 (10)	0.80

Hypothesis testing was performed using t-test for comparison of means for normally distributed variables and Wilcoxon rank test for non-normally distributed (denoted with *). Values are mean (± Standard deviation) or median (Interquartile range), denoted with #.

ABI: ankle brachial index, DBP: diastolic blood pressure, G3: Galectin 3, Hs-CRP: High sensitivity C-Reactive protein, HOMA: Homeostasis Model Assessment, LAEI: Large Artery Elasticity Index, SAEI: Small Artery Elasticity Index, SBP: Systolic blood pressure, UACR: Urinary albumin/creatinine ratio.